- Home
- MSC vs CVAC Comparison
MSC vs CVAC Comparison
Compare MSC & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSC
- CVAC
- Stock Information
- Founded
- MSC 2000
- CVAC 2000
- Country
- MSC Hong Kong
- CVAC Germany
- Employees
- MSC N/A
- CVAC N/A
- Industry
- MSC Hotels/Resorts
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- MSC Consumer Discretionary
- CVAC Health Care
- Exchange
- MSC Nasdaq
- CVAC Nasdaq
- Market Cap
- MSC 1.0B
- CVAC 812.1M
- IPO Year
- MSC 2018
- CVAC 2020
- Fundamental
- Price
- MSC $4.80
- CVAC $4.10
- Analyst Decision
- MSC
- CVAC Hold
- Analyst Count
- MSC 0
- CVAC 3
- Target Price
- MSC N/A
- CVAC $10.00
- AVG Volume (30 Days)
- MSC 17.2K
- CVAC 1.2M
- Earning Date
- MSC 02-27-2025
- CVAC 11-12-2024
- Dividend Yield
- MSC N/A
- CVAC N/A
- EPS Growth
- MSC N/A
- CVAC N/A
- EPS
- MSC N/A
- CVAC N/A
- Revenue
- MSC $627,533,000.00
- CVAC $70,565,734.00
- Revenue This Year
- MSC $33.86
- CVAC $742.57
- Revenue Next Year
- MSC $16.73
- CVAC N/A
- P/E Ratio
- MSC N/A
- CVAC N/A
- Revenue Growth
- MSC 103.40
- CVAC 75.11
- 52 Week Low
- MSC $4.12
- CVAC $2.22
- 52 Week High
- MSC $9.30
- CVAC $5.28
- Technical
- Relative Strength Index (RSI)
- MSC 36.84
- CVAC 62.06
- Support Level
- MSC $4.12
- CVAC $3.89
- Resistance Level
- MSC $4.95
- CVAC $4.32
- Average True Range (ATR)
- MSC 0.54
- CVAC 0.33
- MACD
- MSC -0.06
- CVAC 0.03
- Stochastic Oscillator
- MSC 25.28
- CVAC 54.27
About MSC Studio City International Holdings Limited
Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including 15 tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.